Tagomics, a biomarker discovery and diagnostics company, has announced it has been awarded £860k Innovate UK funding as part of the Biomedical Catalyst programme for the testing and development of innovative healthcare solutions from Innovate UK.
Italfarmaco has announced that the European Commission (EC) has granted conditional marketing authorisation for Duvyzat (givinostat), a novel histone deacetylase (HDAC) inhibitor.
Azenta Life Sciences announce a new range of Electron-Beam (E-Beam) treated externally threaded tubes, expanding options for laboratories and biorepositories that desire sterile sample storage solutions.
CN Bio has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its Contract Research Services (CRS).
MG America, the U.S. subsidiary of MG2 of Bologna, Italy and a supplier of processing and packaging equipment, has introduced a modular tray forming and loading machinery line representing the next generation of its proven GTF60 platform.
Shift Bioscience, a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, has announced the publication of new research identifying a novel, single-gene target for cellular rejuvenation.
Thermo Fisher Scientific has announced the launch of the Thermo Scientific Orbitrap Astral Zoom mass spectrometer (MS) and the Thermo Scientific Orbitrap Excedion Pro mass spectrometer (MS) to help push the boundaries of scientific discovery.
A large-scale international study involving researchers from the Drug Safety Research Unit (DSRU), UK, highlights the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain-Barré syndrome (GBS).
Osivax has announced that all participants have completed their final visit in the Phase 2a clinical booster trial (NCT06582277) evaluating OVX836, Osivax’ broad-spectrum influenza A vaccine candidate.
